Growth Metrics

Biomerica (BMRA) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Biomerica 7.12 Mn 5.78 Mn -44,000.00 -12.81%

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 -12.81%
Nov 30, 2025 -38.95%
Aug 31, 2025 100.15%
May 31, 2025 -15.48%
Feb 28, 2025 39.36%
Nov 30, 2024 36.96%
Aug 31, 2024 -16.25%
May 31, 2024 25.39%
Feb 29, 2024 -16.24%
Nov 30, 2023 7.32%
Aug 31, 2023 45.37%
May 31, 2023 -1.88%
Feb 28, 2023 -1,483.98%
Nov 30, 2022 -44.50%
Aug 31, 2022 -34.32%
May 31, 2022 -2.79%
Feb 28, 2022 95.10%
Nov 30, 2021 34.50%
Aug 31, 2021 6.48%
May 31, 2021 -109.38%
Feb 28, 2021 -146.77%
Nov 30, 2020 -254.06%
Aug 31, 2020 -225.78%
May 31, 2020 -7.38%
Feb 29, 2020 -26.84%
Nov 30, 2019 -1.68%
Aug 31, 2019 -12.08%
May 31, 2019 -19.70%
Feb 28, 2019 -110.47%
Nov 30, 2018 -77.64%
Aug 31, 2018 -118.17%
May 31, 2018 -83.86%
Feb 28, 2018 -6.03%
Nov 30, 2017 -32.42%
Aug 31, 2017 -273.64%
May 31, 2017 71.79%
Feb 28, 2017 -125.29%
Nov 30, 2016 -203.87%
Aug 31, 2016 23.39%
May 31, 2016 -2,131.47%
Feb 29, 2016 -15.20%
Nov 30, 2015 71.95%
Aug 31, 2015 67.01%
May 31, 2015 -14.13%
Feb 28, 2015 -541.50%
Nov 30, 2014 2.19%
Aug 31, 2014 -30.74%
May 31, 2014 -190.77%
Feb 28, 2014 174.53%
Nov 30, 2013 -202.72%
Aug 31, 2013 -157.51%
May 31, 2013 -36.21%
Feb 28, 2013 -119.63%
Nov 30, 2012 21.44%
Aug 31, 2012 147.59%
May 31, 2012 -13.50%
Feb 29, 2012 147.19%
Nov 30, 2011 209.95%